Kisunla

Pharma

ExCellThera's novel blood cancer cell therapy gains CHMP nod

Among its positive recommendations, Europe’s CHMP has blessed ExCellThera’s Zemcelpro, a stem cell transplant treatment for adults with blood cancers.

Kevin Dunleavy Jun 20, 2025 11:55am

Europe's CHMP turns down Lilly's Alzheimer's drug Kisunla

Mar 28, 2025 11:36am

Lilly adds Alzheimer's disease care to DTC telehealth platform

Mar 27, 2025 10:34am

NICE again rejects Alzheimer's drugs from Lilly and Biogen/Eisai

Mar 6, 2025 10:47am

brain amyloid alzheimers strings detailed web complicated thought

Analysts tip Lilly to drive eightfold Alzheimer's market boom

Jan 17, 2025 9:00am

Breaking down the 55 new drug approvals of 2024

Jan 10, 2025 9:00am